Perelman School of Medicine

Penn Medicine: Gorilla Origins of the Last Two AIDS Virus Lineages Confirmed

Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to an international team of scientists from the Perelman School of Medicine at the University of Pennsylvania, the University of Montpellier, the University of Edinburgh, and others.

Karen Kreeger

Prescription Drug-Induced Liver Failure is Uncommon; Over-the-Counter Medications and Dietary/Herbal Supplements are Most Common Causes, Penn Study Finds

Drug-induced acute liver failure is uncommon, and over-the-counter medications and dietary and herbal supplements -- not prescription drugs -- are its most common causes, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The findings are published in the current issue of Gastroenterology.

Lee-Ann Donegan

Successful Cognitive Behavioral Therapy in Youth Leads to Decreased Thinking about Suicide, Penn Medicine Study Finds

Penn Medicine researchers found that patients who did not respond to cognitive behavioral therapy (CBT) for anxiety in childhood had more chronic and enduring patterns of suicidal ideation at 7 to 19 years after treatment. This study adds to the literature that suggests that successful CBT for childhood anxiety confers long-term benefits. The complete study is available in the Journal of the American Academy of Child & Adolescent Psychiatry.

Lee-Ann Donegan

Penn Medicine Physician Finds No Preventive Benefits for Widely Used Kidney Cancer Drugs

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania’s 

Steve Graff

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsy

Holly Auer



In the News


Slate.com

What’s going on with tranq?

Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.

FULL STORY →



The Hill

It’s time to end the Medicare-Medicaid merry-go-round

In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.

FULL STORY →



Philadelphia Inquirer

Inside Penn’s transfer center

Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.

FULL STORY →



Philadelphia Inquirer

Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use

Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.

FULL STORY →



Philadelphia Inquirer

Broad Street runners from Penn are racing with gyroscopes to study the Achilles tendon

Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.

FULL STORY →